MERCURI, NICOLA BIAGIO
 Distribuzione geografica
Continente #
NA - Nord America 70.979
EU - Europa 4.886
AS - Asia 2.825
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 22
AF - Africa 2
Totale 78.782
Nazione #
US - Stati Uniti d'America 70.933
SG - Singapore 1.285
CN - Cina 946
IT - Italia 901
IE - Irlanda 896
UA - Ucraina 869
DE - Germania 660
KR - Corea 426
FR - Francia 299
GB - Regno Unito 266
SE - Svezia 263
RU - Federazione Russa 212
FI - Finlandia 182
PL - Polonia 145
CZ - Repubblica Ceca 39
BE - Belgio 38
CA - Canada 38
JP - Giappone 37
IN - India 28
EU - Europa 27
BR - Brasile 25
NL - Olanda 24
AU - Australia 19
KG - Kirghizistan 19
VN - Vietnam 18
RO - Romania 16
CH - Svizzera 14
UZ - Uzbekistan 10
DK - Danimarca 9
ES - Italia 9
HK - Hong Kong 7
IR - Iran 7
PT - Portogallo 7
AT - Austria 6
BD - Bangladesh 6
CL - Cile 6
AL - Albania 5
GR - Grecia 5
HU - Ungheria 5
MX - Messico 5
NO - Norvegia 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
TH - Thailandia 4
TW - Taiwan 4
AR - Argentina 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
DM - Dominica 2
IL - Israele 2
JO - Giordania 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
CR - Costa Rica 1
EG - Egitto 1
GE - Georgia 1
ID - Indonesia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 78.782
Città #
Woodbridge 19.260
Wilmington 18.992
Houston 17.515
Fairfield 2.882
Ann Arbor 1.548
Chandler 1.380
Ashburn 1.313
Singapore 1.126
Seattle 1.121
Cambridge 946
Dublin 796
Jacksonville 742
Medford 596
Rome 379
Beijing 355
Dearborn 351
Santa Clara 329
New York 319
Lawrence 277
Zhengzhou 254
Menlo Park 169
San Diego 134
Kraków 133
Moscow 115
Norwalk 82
Shanghai 76
Milan 74
Redwood City 53
Mountain View 52
London 48
Seoul 45
Boardman 44
Mülheim 43
Nanjing 42
Palo Alto 42
Brussels 38
Brno 36
Munich 36
Detroit 35
Hefei 32
University Park 32
Verona 31
Phoenix 29
Falls Church 28
Durham 27
Engelhard 26
Toronto 24
Creede 23
Guangzhou 23
Kilburn 22
San Jose 22
Washington 21
Redmond 19
Council Bluffs 18
Kunming 18
Daejeon 16
Dong Ket 16
San Francisco 16
Philadelphia 15
São Paulo 15
Los Angeles 14
Saint Petersburg 14
San Mateo 14
Chicago 13
Monmouth Junction 13
Naples 13
Pune 13
Wuhan 13
Indiana 12
Fuzhou 11
Hangzhou 11
Helsinki 11
Nuremberg 11
Garden City 10
Hounslow 10
Nanchang 10
Roebling 10
Tokyo 10
Turin 10
Chongqing 8
Lappeenranta 8
Mcallen 8
Montesilvano Marina 8
Palermo 8
Warsaw 8
Amsterdam 7
Chengdu 7
Hebei 7
Jinan 7
Prescot 7
Changsha 6
Frankfurt am Main 6
Hanover 6
Kyiv 6
New Bedfont 6
Sacramento 6
Simi Valley 6
Southwark 6
Atlanta 5
Budapest 5
Totale 72.615
Nome #
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine 471
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 450
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 447
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 447
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis 444
Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice 441
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase 436
Insulin receptor β-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory 435
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 434
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 433
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 430
Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusion 429
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 428
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation 427
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 427
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 427
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro 425
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 422
The Blockade of K+-ATP channels has neuroprotective effects in an in vitro model of brain ischemia 421
Age-related changes of hippocampal synaptic plasticity in AβPP-null mice are restored by NGF through p75NTR 420
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release 418
The role of adiponectin receptors in the regulation of synaptic transmission in the hippocampus 417
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 416
Inhibition of hippocampal plasticity in rats performing contrafreeloading for water under repeated administrations of pramipexole 416
A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation 415
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP 412
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 409
Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels' activation in a genetic model of amyotrophic lateral sclerosis 408
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 408
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 407
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study. 407
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 406
Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro 405
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 405
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 405
Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism 404
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 404
Voltage-activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS 403
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 403
Over-expression of N-type calcium channels in cortical neurons from a mouse model of Amyotrophic Lateral Sclerosis 402
Synaptic plasticity in the basal ganglia: a similar code for physiological and pathological conditions 401
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 401
Gamma-hydroxybutyrate and ethanol depress spontaneous excitatory postsynaptic currents in dopaminergic neurons of the substantia nigra 400
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy 400
Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 400
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration 399
Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons 399
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 398
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 397
Effects of Phenobarbital and Levetiracetam on PR and QTc Intervals in Patients with Post-Stroke Seizure 397
Increased D-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice 396
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 396
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 395
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study 395
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 395
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease 395
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 394
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 394
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 394
Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions 393
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 393
Electrophysiologic Changes in Ventral Midbrain Dopaminergic Neurons Resulting from (+/-) -3,4-Methylenedioxymethamphetamine (MDMA-"Ecstasy") 393
N-ethyl lidocaine (QX-314) protects striatal neurons against ischemia: an in vitro electrophysiological study 392
Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons 391
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. 391
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 391
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility 390
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 390
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 390
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 390
Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia 390
Familiar trajectories facilitate the interpretation of physical forces when intercepting a moving target 389
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 389
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 388
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 388
Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice 388
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 387
Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine 386
Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate 386
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 386
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 385
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 384
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis 384
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta 382
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 381
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 381
Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation 381
Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease 381
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 378
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 378
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 378
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals 378
Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism 378
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons 378
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 377
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 377
Cu/Zn-superoxide dismutase (GLY93-->ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture 376
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 376
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 375
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 375
Totale 40.174
Categoria #
all - tutte 166.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018.692 0 0 1.506 1.993 1.722 2.180 1.898 2.188 2.212 1.865 1.485 1.643
2020/202113.517 1.579 1.585 1.473 1.642 1.467 1.416 1.602 1.312 333 426 518 164
2021/20223.296 153 294 153 128 108 247 393 134 162 289 227 1.008
2022/20233.752 420 297 172 421 304 832 364 287 341 57 145 112
2023/20241.695 173 51 105 53 142 398 116 193 41 112 48 263
2024/20252.345 298 1.693 354 0 0 0 0 0 0 0 0 0
Totale 80.139